Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of the efficacy and safety of a proposed biosimilar MSB11456 with tocilizumab reference product in subjects with moderate-to-severe rheumatoid arthritis: results of a randomised double-blind study.
Zubrzycka-Sienkiewicz A, Klama K, Ullmann M, Petit-Frere C, Baker P, Monnet J, Illes A. Zubrzycka-Sienkiewicz A, et al. Among authors: monnet j. RMD Open. 2024 Feb 5;10(1):e003596. doi: 10.1136/rmdopen-2023-003596. RMD Open. 2024. PMID: 38316489 Free PMC article. Clinical Trial.
Pharmacokinetics and tolerability of prefilled syringe and auto-injector presentations of MSB11456: results of a randomized, single-dose study in healthy adults.
Tomaszewska-Kiecana M, Dryja A, Ullmann M, Petit-Frere C, Illes A, Dagres C, Monnet J. Tomaszewska-Kiecana M, et al. Among authors: monnet j. Expert Rev Clin Immunol. 2023 Apr;19(4):447-455. doi: 10.1080/1744666X.2023.2174970. Epub 2023 Feb 15. Expert Rev Clin Immunol. 2023. PMID: 36789991 Clinical Trial.
Insurance Status of Mothers at the Time of Birth, by Demographic Characteristics, 2008-2019.
Monnet J, Hudson J. Monnet J, et al. 2023 Feb. In: Statistical Brief (Medical Expenditure Panel Survey (US)) [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2001–. STATISTICAL BRIEF #547. 2023 Feb. In: Statistical Brief (Medical Expenditure Panel Survey (US)) [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2001–. STATISTICAL BRIEF #547. PMID: 37616439 Free Books & Documents. Review.
Pharmacokinetics of a proposed tocilizumab biosimilar (MSB11456) versus US-licensed tocilizumab: results of a randomized, double-blind, single-intravenous dose study in healthy adults.
Tomaszewska-Kiecana M, Ullmann M, Petit-Frere C, Monnet J, Dagres C, Illes A. Tomaszewska-Kiecana M, et al. Among authors: monnet j. Expert Rev Clin Immunol. 2023 Apr;19(4):439-446. doi: 10.1080/1744666X.2023.2174104. Epub 2023 Feb 13. Expert Rev Clin Immunol. 2023. PMID: 36715299 Clinical Trial.
Pharmacokinetics and pharmacodynamics of a proposed tocilizumab biosimilar MSB11456 versus both the US-licensed and EU-approved products: a randomized, double-blind trial.
Schwabe C, Illes A, Ullmann M, Ghori V, Vincent E, Petit-Frere C, Monnet J, Racault AS, Wynne C. Schwabe C, et al. Among authors: monnet j. Expert Rev Clin Immunol. 2022 May;18(5):533-543. doi: 10.1080/1744666X.2022.2060204. Epub 2022 Apr 10. Expert Rev Clin Immunol. 2022. PMID: 35354411 Clinical Trial.
47 results